Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 1 February 1980:
Vol. 207. no. 4430, pp. 535 - 537
DOI: 10.1126/science.7352264

Articles

Science, Vol 207, Issue 4430, 535-537
Copyright © 1980 by American Association for the Advancement of Science


articles

Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?

RB Mailman, RM Ferris, FL Tang, RA Vogel, CD Kilts, MA Lipton, DA Smith, RA Mueller, and GR Breese

Biochemical studies have shown that the ability of erythrosine to inhibit dopamine uptake into brain synaptosomal preparations is dependent on the concentration of tissue present in the assay mixture. Thus, the finding that erythrosine inhibits dopamine uptake (which, if true, would provide a plausible explanation of the Feingold hypothesis of childhood hyperactivity) may simply be an artifact that results from nonspecific interactions with brain membranes. In addition, although erythrosine given parenterally (50 milligrams per kilogram) did not alter locomotor activity of control of 6-hydroxydopamine-treated rats, erythrosine (50 to 300 milligrams per kilogram) attenuated the effect of punishment in a "conflict" paradigm.





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)